Showing results (251-260 of 721) with videos related to
Sort By:
Pageof 73
Movement Disorders : Official Journal of the Movement Disorder Society|August 19, 2008
SCOPA-sleep and PDSS: two scales for assessment of sleep disorder in Parkinson's diseasePablo Martinez-Martin, Martine Visser, Carmen Rodriguez-Blazquez, et al.BMJ Mental Health|July 23, 2024
Parkinson's disease psychosis associated with accelerated multidomain cognitive declineSara Pisani, Luca Gosse, Dag Aarsland, et al.European Journal of Neurology|July 25, 2023
Opicapone versus entacapone: Head-to-head retrospective data-based comparison of healthcare resource utilization in people with Parkinson's disease new to catechol-O-methyltransferase (COMT) inhibitor treatmentGlynn Harrison-Jones, Xiaocong Li Marston, Francesca Morgante, et al.CNS Drugs|February 9, 2021
Rotigotine Transdermal Patch for Motor and Non-motor Parkinson's Disease: A Review of 12 Years' Clinical ExperienceVanessa Raeder, Iro Boura, Valentina Leta, et al.Movement Disorders Clinical Practice|October 27, 2018
Clinical Determinants of Parkinson's Disease-associated Pain Using the King's Parkinson's Disease Pain ScaleMayela Rodríguez-Violante, Alonso Alvarado-Bolaños, Amin Cervantes-Arriaga, et al.Journal of Parkinson'S Disease|June 30, 2020
Opicapone and Levodopa-Carbidopa Intestinal Gel Infusion: The Way Forward Towards Cost Savings for Healthcare Systems?Valentina Leta, Daniel J van Wamelen, Anna Sauerbier, et al.Biorxiv : the Preprint Server for Biology|April 1, 2024
5-HT1B receptors mediate dopaminergic inhibition of vesicular fusion and GABA release from striatonigral synapsesMaya Molinari, Ori J Lieberman, David Sulzer, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 5, 2003
D3 dopamine autoreceptors do not activate G-protein-gated inwardly rectifying potassium channel currents in substantia nigra dopamine neuronsViviana Davila, Zhen Yan, Liviu C Craciun, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 17, 2009
Dopamine cell implantation in Parkinson's disease: long-term clinical and (18)F-FDOPA PET outcomesYilong Ma, Chengke Tang, Thomas Chaly, et al.Movement Disorders : Official Journal of the Movement Disorder Society|February 11, 2021
Cytokines and Gaucher Biomarkers in Glucocerebrosidase Carriers with and Without Parkinson DiseaseJasmin Galper, Manisha Balwani, Stanley Fahn, et al.Pageof 73